Rhenman & Partners Asset Management AB Has $34.25 Million St

Rhenman & Partners Asset Management AB reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 39,000 shares of the biopharmaceutical company’s stock after selling 1,000 shares during the […]

Related Keywords

Los Angeles , California , United States , Sanfordc Bernstein , Andrewj Murphy , Michaels Brown , , News Ratings For Regeneron Pharmaceuticals Daily , Regeneron Pharmaceuticals , Financial Group , Regeneron Pharmaceuticals Inc , Morgan Stanley , Quarter For Regeneron Pharmaceuticals , Nasdaq , Regeneron Pharmaceuticals Stock , Los Angeles Capital Management , Exchange Commission , Cantor Fitzgerald , Savant Capital , Partners Asset Management , Free Report , Angeles Capital Management , Merit Financial Group , Get Free Report , Director Michael , Regeneron Pharmaceuticals Daily ,